EMA Advises Using COVID-19 Approaches to Support Ukrainian Clinical Trials
May 3, 2022
The European Medicines Agency (EMA) has called on sponsors conducting trials in Ukraine to address disruptions related to the current conflict by applying strategies used to address the pandemic where and when they can.